Citations 2
Health care costs among patients with relapsed/refractory multiple myeloma treated with ixazomib or daratumumab in combination with lenalidomide and dexamethasone in the United States
Cheng, Mu , DerSarkissian, Maral , Dabora, Jonathan, Young, Melanie , Noga, Stephen J. , Pi, Selina , Banatwala, Azeem , Duh, Mei Sheng , Cherepanov, Dasha , Ailawadhi, Sikander , Zhang, Melody
Journal of Managed Care & Specialty Pharmacy | September 9, 2024 | Volume: 30 | Issue: 12 | Pages: 1431-1441
Comparison of health care costs and resource utilization for commonly used proteasome inhibitor–immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States
Sanchez, Larysa , Cheng, Mu, Cherepanov, Dasha , DerSarkissian, Maral , Stull, Dawn Marie, Dabora, Jonathan, Young, Melanie , Noga, Stephen J. , Pi, Selina , Banatwala, Azeem , Duh, Mei Sheng , Chari, Ajai , Chari, Ajai , Huang, Fei, Zhang, Melody , Ailawadhi, Sikander
Journal of Managed Care & Specialty Pharmacy | September 30, 2023 | Volume: 29 | Issue: 11 | Pages: 1205-1218